Thomson Medical (SGX:A50) expects to swing to a loss after tax for the fiscal first half ended Dec. 31, 2024, after booking a SG$4.9 million profit in the year-ago period, according to a filing with the Singapore Exchange on Friday.
The company attributed the anticipated loss to the "poorer performance" of the Malaysian market, resulting from the termination of certain insurance contracts and increased expenses.
The company is expected to release its financial results on or before Feb. 14.